Home/Filings/4/0001140361-22-020789
4//SEC Filing

Watts Charles M 4

Accession 0001140361-22-020789

CIK 0001439725other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:16 PM ET

Size

6.0 KB

Accession

0001140361-22-020789

Insider Transaction Report

Form 4
Period: 2022-05-24
Transactions
  • Award

    Restricted Stock Units

    2022-05-24+83,33383,333 total
    Common Stock (83,333 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock and has no expiration date.
  • [F2]These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period.
  • [F3]The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period.

Issuer

BIODESIX INC

CIK 0001439725

Entity typeother

Related Parties

1
  • filerCIK 0001723751

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:16 PM ET
Size
6.0 KB